

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.14454961 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.14454961 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.14454961 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.14454961 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.14454961 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.14454961 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.93308716 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.93308716 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.72073024 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.47373546 |
| 11 | detection of other organism (GO:0098543) | 5.31425516 |
| 12 | response to peptidoglycan (GO:0032494) | 5.22954382 |
| 13 | detection of bacterium (GO:0016045) | 5.17979747 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.13496243 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.95050962 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.94137886 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.79701590 |
| 18 | leukocyte aggregation (GO:0070486) | 4.78358156 |
| 19 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.67397586 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.49678413 |
| 21 | neutrophil activation (GO:0042119) | 4.44872497 |
| 22 | respiratory burst (GO:0045730) | 4.36268624 |
| 23 | cellular extravasation (GO:0045123) | 4.31914693 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.25000282 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 4.24901432 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.23579021 |
| 27 | response to host immune response (GO:0052572) | 4.21704888 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.21704888 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.11776424 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 4.08936801 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04759661 |
| 32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.03133684 |
| 33 | detection of biotic stimulus (GO:0009595) | 4.01715341 |
| 34 | granulocyte activation (GO:0036230) | 4.00246351 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.94986748 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.93591737 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86314702 |
| 38 | response to host (GO:0075136) | 3.84970519 |
| 39 | response to host defenses (GO:0052200) | 3.84970519 |
| 40 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.84970519 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.77257591 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.75183691 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.71142538 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.70669734 |
| 45 | macrophage activation (GO:0042116) | 3.69728472 |
| 46 | microglial cell activation (GO:0001774) | 3.69595875 |
| 47 | neutrophil mediated immunity (GO:0002446) | 3.69553154 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.59564670 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.58155048 |
| 50 | regulation of leukocyte degranulation (GO:0043300) | 3.54993596 |
| 51 | positive regulation of mast cell activation (GO:0033005) | 3.46461194 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43159802 |
| 53 | leukocyte degranulation (GO:0043299) | 3.42662694 |
| 54 | response to interleukin-15 (GO:0070672) | 3.33819983 |
| 55 | regulation of mast cell activation (GO:0033003) | 3.33424968 |
| 56 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.33352384 |
| 57 | response to muramyl dipeptide (GO:0032495) | 3.32609152 |
| 58 | negative regulation of phagocytosis (GO:0050765) | 3.32562500 |
| 59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30377286 |
| 60 | regulation of regulated secretory pathway (GO:1903305) | 3.25878462 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.24235392 |
| 62 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.21434356 |
| 63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.20647433 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.19075580 |
| 65 | germinal center formation (GO:0002467) | 3.16958187 |
| 66 | myeloid leukocyte mediated immunity (GO:0002444) | 3.16834353 |
| 67 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.15475469 |
| 68 | negative regulation of interleukin-6 production (GO:0032715) | 3.10169074 |
| 69 | cellular response to type I interferon (GO:0071357) | 3.09677640 |
| 70 | type I interferon signaling pathway (GO:0060337) | 3.09677640 |
| 71 | response to type I interferon (GO:0034340) | 3.08640992 |
| 72 | defense response to protozoan (GO:0042832) | 3.04989694 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 3.02674327 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02674327 |
| 75 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.02095362 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97086208 |
| 77 | regulation of T cell tolerance induction (GO:0002664) | 2.97063472 |
| 78 | cellular response to interleukin-15 (GO:0071350) | 2.96357052 |
| 79 | B cell mediated immunity (GO:0019724) | 2.95564958 |
| 80 | neutrophil chemotaxis (GO:0030593) | 2.95100146 |
| 81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95096493 |
| 82 | regulation of tolerance induction (GO:0002643) | 2.93767641 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93137243 |
| 84 | negative regulation of type 2 immune response (GO:0002829) | 2.90612408 |
| 85 | B cell receptor signaling pathway (GO:0050853) | 2.88758512 |
| 86 | positive regulation of regulated secretory pathway (GO:1903307) | 2.87591825 |
| 87 | neutrophil migration (GO:1990266) | 2.87481475 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.82953906 |
| 89 | tolerance induction (GO:0002507) | 2.79575674 |
| 90 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.77114747 |
| 91 | myeloid leukocyte activation (GO:0002274) | 2.76978786 |
| 92 | actin filament polymerization (GO:0030041) | 2.74588526 |
| 93 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.74069287 |
| 94 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.73352494 |
| 95 | response to protozoan (GO:0001562) | 2.71627932 |
| 96 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70800205 |
| 97 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.69996661 |
| 98 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69915336 |
| 99 | positive thymic T cell selection (GO:0045059) | 2.69861152 |
| 100 | regulation of B cell differentiation (GO:0045577) | 2.67904532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.06631813 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.54391068 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.35320494 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01798098 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.90033553 |
| 6 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.68044516 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.57830366 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.53037703 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48166071 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44311252 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42821218 |
| 12 | SPI1_23127762_ChIP-Seq_K562_Human | 2.38659855 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35083345 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.31698273 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.30984715 |
| 16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.27835656 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.27384670 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.25606231 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.25533922 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.24730208 |
| 21 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.22366027 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.17270436 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.16973161 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15905389 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15213919 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.06751121 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02297476 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.01589115 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98358395 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92841100 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91854178 |
| 32 | * MAF_26560356_Chip-Seq_TH2_Human | 1.89504701 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77461954 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77093774 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75831837 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71918951 |
| 37 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67935283 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64849338 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63456313 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62341040 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.58259898 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57879266 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.56311738 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55787129 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53441836 |
| 46 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.52341160 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51236172 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49738267 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.48818863 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.46599329 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44698505 |
| 52 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41669267 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.40638097 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39990913 |
| 55 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.38793343 |
| 56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38581334 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38491031 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38112557 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37314145 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.36231881 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35809796 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35354951 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35193402 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34398772 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33956739 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33731900 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32853803 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30933736 |
| 69 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28359076 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23759500 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23691235 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19927834 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19866907 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19844946 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17902970 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17131583 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15231685 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14899600 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14668899 |
| 80 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13541912 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13180055 |
| 82 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10672747 |
| 83 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10404248 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08921764 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08133094 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08078725 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07970411 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07713368 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07508908 |
| 90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07451129 |
| 91 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05993098 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05444294 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05324655 |
| 94 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04184104 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01413459 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99793306 |
| 97 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99586283 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99301346 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97940583 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97598339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.01624518 |
| 2 | MP0003436_decreased_susceptibility_to | 4.53838912 |
| 3 | MP0003303_peritoneal_inflammation | 3.84641971 |
| 4 | MP0002419_abnormal_innate_immunity | 3.19212613 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.18780560 |
| 6 | MP0005025_abnormal_response_to | 2.89049064 |
| 7 | MP0005387_immune_system_phenotype | 2.61559400 |
| 8 | MP0001790_abnormal_immune_system | 2.61559400 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.57909230 |
| 10 | MP0001800_abnormal_humoral_immune | 2.57351881 |
| 11 | MP0006082_CNS_inflammation | 2.57276333 |
| 12 | MP0009785_altered_susceptibility_to | 2.57271604 |
| 13 | MP0000685_abnormal_immune_system | 2.50264455 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.46973948 |
| 15 | MP0005671_abnormal_response_to | 2.42970040 |
| 16 | MP0002723_abnormal_immune_serum | 2.39892842 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.35610214 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.33816709 |
| 19 | MP0001819_abnormal_immune_cell | 2.33805870 |
| 20 | MP0009278_abnormal_bone_marrow | 2.33116804 |
| 21 | MP0008260_abnormal_autophagy | 2.29515435 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.28703618 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.26221867 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.15335837 |
| 25 | MP0002132_abnormal_respiratory_system | 2.10939970 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.08633581 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.99171151 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.98488757 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.95078027 |
| 30 | MP0003828_pulmonary_edema | 1.88256312 |
| 31 | MP0002405_respiratory_system_inflammati | 1.85085862 |
| 32 | MP0005451_abnormal_body_composition | 1.74710614 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.70762868 |
| 34 | MP0004381_abnormal_hair_follicle | 1.70105720 |
| 35 | MP0000716_abnormal_immune_system | 1.69740086 |
| 36 | MP0003866_abnormal_defecation | 1.68014172 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.67582803 |
| 38 | MP0002398_abnormal_bone_marrow | 1.65670928 |
| 39 | MP0002277_abnormal_respiratory_mucosa | 1.58958416 |
| 40 | MP0004947_skin_inflammation | 1.58304317 |
| 41 | MP0004510_myositis | 1.57162097 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.48479120 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.46343631 |
| 44 | MP0008469_abnormal_protein_level | 1.45723423 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.43134804 |
| 46 | MP0005083_abnormal_biliary_tract | 1.39071867 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.38421436 |
| 48 | MP0009764_decreased_sensitivity_to | 1.37848371 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.33795005 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.33795005 |
| 51 | MP0002722_abnormal_immune_system | 1.33610753 |
| 52 | MP0002429_abnormal_blood_cell | 1.32692118 |
| 53 | MP0005310_abnormal_salivary_gland | 1.31951371 |
| 54 | MP0003075_altered_response_to | 1.28065304 |
| 55 | MP0004858_abnormal_nervous_system | 1.20707403 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.20536909 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.20457298 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.18687767 |
| 59 | MP0000858_altered_metastatic_potential | 1.18241393 |
| 60 | MP0001851_eye_inflammation | 1.17025116 |
| 61 | MP0004883_abnormal_blood_vessel | 1.14757865 |
| 62 | MP0001873_stomach_inflammation | 1.14357280 |
| 63 | MP0003878_abnormal_ear_physiology | 1.14331546 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.14331546 |
| 65 | MP0002653_abnormal_ependyma_morphology | 1.01767788 |
| 66 | MP0005390_skeleton_phenotype | 1.00965606 |
| 67 | MP0003690_abnormal_glial_cell | 0.99820237 |
| 68 | MP0001663_abnormal_digestive_system | 0.97290729 |
| 69 | MP0001986_abnormal_taste_sensitivity | 0.96844486 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 0.96833937 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.96103632 |
| 72 | MP0005248_abnormal_Harderian_gland | 0.93489246 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 0.84645729 |
| 74 | MP0000343_altered_response_to | 0.81944899 |
| 75 | MP0005164_abnormal_response_to | 0.80060483 |
| 76 | MP0000490_abnormal_crypts_of | 0.79729671 |
| 77 | MP0005166_decreased_susceptibility_to | 0.78545857 |
| 78 | MP0008004_abnormal_stomach_pH | 0.76210912 |
| 79 | MP0002928_abnormal_bile_duct | 0.75789642 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.75174118 |
| 81 | MP0004130_abnormal_muscle_cell | 0.74254754 |
| 82 | MP0000604_amyloidosis | 0.72660426 |
| 83 | MP0000470_abnormal_stomach_morphology | 0.69537031 |
| 84 | MP0002933_joint_inflammation | 0.69383512 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.67601002 |
| 86 | MP0008874_decreased_physiological_sensi | 0.66773525 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.63354637 |
| 88 | MP0003795_abnormal_bone_structure | 0.63094265 |
| 89 | MP0005381_digestive/alimentary_phenotyp | 0.61961621 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.61893365 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.58927281 |
| 92 | MP0003879_abnormal_hair_cell | 0.58613504 |
| 93 | MP0009763_increased_sensitivity_to | 0.57723957 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.57191307 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.56630280 |
| 96 | MP0001853_heart_inflammation | 0.55877193 |
| 97 | MP0009840_abnormal_foam_cell | 0.55494940 |
| 98 | MP0003787_abnormal_imprinting | 0.55118229 |
| 99 | MP0004264_abnormal_extraembryonic_tissu | 0.53927030 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.53247990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.66613583 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.15027368 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.90772244 |
| 4 | Myositis (HP:0100614) | 5.72369005 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.63320467 |
| 6 | Orchitis (HP:0100796) | 5.29104871 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.06127259 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.93124582 |
| 9 | Stomatitis (HP:0010280) | 4.73056817 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.69281378 |
| 11 | Optic neuritis (HP:0100653) | 4.69281378 |
| 12 | Obstructive lung disease (HP:0006536) | 4.60540521 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.60540521 |
| 14 | Hypochromic microcytic anemia (HP:0004840) | 4.52066510 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.20321736 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 4.05946175 |
| 17 | Hypochromic anemia (HP:0001931) | 4.02549552 |
| 18 | Increased IgE level (HP:0003212) | 4.00013608 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.91005179 |
| 20 | Recurrent skin infections (HP:0001581) | 3.74780654 |
| 21 | Meningitis (HP:0001287) | 3.69702771 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.68872352 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.63560619 |
| 24 | Urticaria (HP:0001025) | 3.52261791 |
| 25 | Gingivitis (HP:0000230) | 3.44410501 |
| 26 | Encephalitis (HP:0002383) | 3.40679260 |
| 27 | Prolonged bleeding time (HP:0003010) | 3.36641143 |
| 28 | Episodic fever (HP:0001954) | 3.28194965 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 3.20012462 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16909622 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16909622 |
| 32 | Chest pain (HP:0100749) | 3.14572642 |
| 33 | Vasculitis (HP:0002633) | 3.13028728 |
| 34 | Peritonitis (HP:0002586) | 3.09035638 |
| 35 | Amyloidosis (HP:0011034) | 3.02469544 |
| 36 | Cellulitis (HP:0100658) | 2.99758539 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.94530142 |
| 38 | Hemoptysis (HP:0002105) | 2.85221803 |
| 39 | Petechiae (HP:0000967) | 2.84349862 |
| 40 | Microcytic anemia (HP:0001935) | 2.68916013 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 2.68550564 |
| 42 | Anorexia (HP:0002039) | 2.67441763 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.66269102 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.65011964 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.62252838 |
| 46 | Gingival bleeding (HP:0000225) | 2.61647995 |
| 47 | Epistaxis (HP:0000421) | 2.55652784 |
| 48 | Arterial thrombosis (HP:0004420) | 2.54078858 |
| 49 | Pulmonary embolism (HP:0002204) | 2.52876728 |
| 50 | Pustule (HP:0200039) | 2.49221455 |
| 51 | Loss of speech (HP:0002371) | 2.42258551 |
| 52 | Leukocytosis (HP:0001974) | 2.40863447 |
| 53 | Purpura (HP:0000979) | 2.40774812 |
| 54 | Increased serum ferritin (HP:0003281) | 2.38714585 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37692087 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37692087 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37692087 |
| 58 | Increased IgM level (HP:0003496) | 2.37011712 |
| 59 | Metaphyseal cupping (HP:0003021) | 2.29990861 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28051012 |
| 61 | Acne (HP:0001061) | 2.28018782 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.26447564 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.25364262 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.23604992 |
| 65 | Sepsis (HP:0100806) | 2.22828630 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.21778422 |
| 67 | Colitis (HP:0002583) | 2.15455193 |
| 68 | Abnormality of iron homeostasis (HP:0011031) | 2.15170770 |
| 69 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.14645168 |
| 70 | Osteomyelitis (HP:0002754) | 2.11774464 |
| 71 | Recurrent viral infections (HP:0004429) | 2.11250779 |
| 72 | Abnormality of the peritoneum (HP:0002585) | 2.10788319 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.07515548 |
| 74 | Granulocytopenia (HP:0001913) | 2.05472580 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05236350 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05236350 |
| 77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05236350 |
| 78 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.04954807 |
| 79 | Abnormality of the endocardium (HP:0004306) | 2.02206652 |
| 80 | Premature loss of primary teeth (HP:0006323) | 1.97997584 |
| 81 | Abnormality of the pericardium (HP:0001697) | 1.97473527 |
| 82 | Gangrene (HP:0100758) | 1.94617542 |
| 83 | Abnormal hemoglobin (HP:0011902) | 1.94389408 |
| 84 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93414977 |
| 85 | Vertigo (HP:0002321) | 1.92724651 |
| 86 | Lymphopenia (HP:0001888) | 1.91549441 |
| 87 | Polycythemia (HP:0001901) | 1.91207686 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88667758 |
| 89 | Mucopolysacchariduria (HP:0008155) | 1.87394773 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87394773 |
| 91 | Hypermelanotic macule (HP:0001034) | 1.86841308 |
| 92 | Nasal polyposis (HP:0100582) | 1.84763755 |
| 93 | Cheilitis (HP:0100825) | 1.84649268 |
| 94 | Hypertensive crisis (HP:0100735) | 1.82194854 |
| 95 | Skin ulcer (HP:0200042) | 1.81491741 |
| 96 | Abnormality of T cells (HP:0002843) | 1.79799517 |
| 97 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.79231358 |
| 98 | Toxemia of pregnancy (HP:0100603) | 1.79189255 |
| 99 | Keratitis (HP:0000491) | 1.78920513 |
| 100 | Abnormality of T cell physiology (HP:0011840) | 1.76925432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.25863318 |
| 2 | ERN1 | 3.40025960 |
| 3 | IRAK4 | 3.31387851 |
| 4 | MAP4K1 | 3.27419054 |
| 5 | TNK2 | 2.98831326 |
| 6 | MAP2K3 | 2.88288540 |
| 7 | BLK | 2.52733496 |
| 8 | EPHB1 | 2.49179108 |
| 9 | TRIB3 | 2.45174943 |
| 10 | GRK6 | 2.37239296 |
| 11 | TYK2 | 2.33475706 |
| 12 | CSK | 2.29809963 |
| 13 | FES | 2.24222436 |
| 14 | TAOK1 | 2.21210828 |
| 15 | MAP3K11 | 2.14924234 |
| 16 | PRPF4B | 2.03703211 |
| 17 | MAP3K3 | 1.80450000 |
| 18 | ZAP70 | 1.80053679 |
| 19 | SIK1 | 1.74914315 |
| 20 | BTK | 1.64067656 |
| 21 | MARK2 | 1.58480662 |
| 22 | SIK3 | 1.57422066 |
| 23 | HCK | 1.51406568 |
| 24 | PRKD2 | 1.44909556 |
| 25 | TBK1 | 1.35093218 |
| 26 | PTK6 | 1.34002392 |
| 27 | JAK3 | 1.33872748 |
| 28 | FGR | 1.29536946 |
| 29 | SMG1 | 1.27333403 |
| 30 | MAP3K1 | 1.26213405 |
| 31 | SYK | 1.20856961 |
| 32 | PKN2 | 1.20555734 |
| 33 | MAP3K13 | 1.18887178 |
| 34 | IKBKE | 1.18171535 |
| 35 | SIK2 | 1.10148178 |
| 36 | JAK2 | 1.09479444 |
| 37 | IRAK2 | 1.08890587 |
| 38 | TAOK2 | 1.05435152 |
| 39 | CSF1R | 1.05241105 |
| 40 | TXK | 1.05195386 |
| 41 | MAP3K7 | 1.04953278 |
| 42 | LYN | 1.04361999 |
| 43 | MARK3 | 1.01759219 |
| 44 | MAP3K14 | 1.00205015 |
| 45 | LRRK2 | 0.99223295 |
| 46 | KSR2 | 0.99175358 |
| 47 | CDK19 | 0.97801152 |
| 48 | LCK | 0.93051777 |
| 49 | PDPK1 | 0.90035538 |
| 50 | MATK | 0.89990058 |
| 51 | RPS6KC1 | 0.87148410 |
| 52 | RPS6KL1 | 0.87148410 |
| 53 | PDK1 | 0.86385690 |
| 54 | KIT | 0.84568318 |
| 55 | IRAK1 | 0.83799153 |
| 56 | TESK2 | 0.83285557 |
| 57 | MAP3K6 | 0.80275977 |
| 58 | ITK | 0.79622396 |
| 59 | RPS6KA6 | 0.76193017 |
| 60 | RPS6KA2 | 0.76179003 |
| 61 | MAP2K4 | 0.73986299 |
| 62 | IKBKB | 0.73497987 |
| 63 | STK11 | 0.72999417 |
| 64 | YES1 | 0.70561639 |
| 65 | MAP2K2 | 0.70358894 |
| 66 | JAK1 | 0.70295118 |
| 67 | HIPK2 | 0.69235221 |
| 68 | DYRK1B | 0.67058978 |
| 69 | CDC42BPA | 0.65175892 |
| 70 | MAPK7 | 0.62939143 |
| 71 | PTK2B | 0.62633581 |
| 72 | CAMKK1 | 0.61538329 |
| 73 | FYN | 0.61059821 |
| 74 | MAP2K6 | 0.60941775 |
| 75 | STK38 | 0.59775258 |
| 76 | TEC | 0.59713957 |
| 77 | MAPK12 | 0.58844547 |
| 78 | TAOK3 | 0.58776531 |
| 79 | IRAK3 | 0.54935786 |
| 80 | PRKG2 | 0.53618128 |
| 81 | RET | 0.51031851 |
| 82 | SGK3 | 0.50821195 |
| 83 | ICK | 0.50451736 |
| 84 | FGFR4 | 0.50442533 |
| 85 | DYRK3 | 0.47404325 |
| 86 | DAPK2 | 0.46127975 |
| 87 | MAPKAPK2 | 0.45317240 |
| 88 | PRKCZ | 0.45218384 |
| 89 | EPHA3 | 0.43856575 |
| 90 | PRKD1 | 0.38776099 |
| 91 | PRKCH | 0.37347855 |
| 92 | RPS6KA1 | 0.34270910 |
| 93 | MAP3K2 | 0.34035224 |
| 94 | CAMK4 | 0.32515963 |
| 95 | TGFBR2 | 0.31684476 |
| 96 | PRKCQ | 0.31388074 |
| 97 | MUSK | 0.31365734 |
| 98 | BMPR2 | 0.31112885 |
| 99 | KDR | 0.30647951 |
| 100 | BMX | 0.29388376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.08046021 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.84288338 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67263439 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.24827409 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15678994 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.09697157 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.05196653 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01795143 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.01201824 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.01088965 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96202912 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.88538379 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.82505128 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.82192481 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.81874425 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72837939 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.71376741 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.60374943 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46120345 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.43592460 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.42482415 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.41916973 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.36890141 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36433962 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35235604 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.33697039 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.32584310 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28793253 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28209567 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.27864517 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.27778661 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.26745636 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26624590 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26456341 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25116314 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24754138 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23958540 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18868361 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17406236 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16393179 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.10442836 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.10235138 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.09183801 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09116702 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07823609 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07378567 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.04189627 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01629085 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01364035 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98092022 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.96635400 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95479452 |
| 53 | Endocytosis_Homo sapiens_hsa04144 | 0.94834700 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.94697874 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93123797 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91264760 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.91057551 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89867728 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89841792 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89565657 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.86593911 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84867984 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84191315 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82916634 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81489773 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80887747 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75512625 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75000605 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72458399 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70665174 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70577595 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70207152 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.69184184 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.68348185 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68035034 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.65166441 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62081653 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61709537 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61234034 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60850567 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60115334 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59490158 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59415663 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58789520 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57624556 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57423151 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56985934 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56235124 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56235123 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53410834 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49673936 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49590106 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49092737 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49014628 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48679140 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46093186 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45937225 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42728693 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39985154 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37961190 |

